Ecolab Inc. (ECL) Cash Flow Statement

The consistent OCF/NI ratio above 1.0 suggests that reported earnings are well-backed by cash generation, with non-cash charges like D&A providing a cushion. The only quarter with OCF/NI below 1 was 2025Q1 (0.92), which coincided with a significant working capital outflow, but this appears to be a seasonal pattern rather than a structural issue. Investors should monitor whether the gap between net income and operating cash flow widens in future quarters, as that could signal deteriorating accruals quality.

The first quarter of 2026 saw a sharp contraction in FCF due to heavy working capital outflows, but the second quarter reversed that trend with a $489.4M FCF print. This volatility appears tied to seasonal payment patterns and inventory builds, rather than a fundamental deterioration. The trailing twelve-month FCF margin of approximately 11% remains below the 2025Q4 peak of 18.1%, but the upward trajectory suggests the company is regaining its cash generation capacity.

The capital expenditure ratio is moderate for a specialty chemical company, but it understates the true capital intensity because the company often places equipment at customer sites without upfront cost. The depreciation of these assets is captured in D&A, which has been relatively stable around $230-270M per quarter, suggesting a steady replacement cycle. The elevated CapEx in 2026Q1 (8.6% of revenue) may indicate a push into growth areas like life sciences, but the subsequent quarter's normalization suggests a return to maintenance-level spending.

The large negative working capital changes in the first half of 2026 suggest that the company is investing in receivables and inventory to support growth, but the magnitude of the swings is notable. The positive working capital contribution in 2025Q4 and 2024Q3 indicates that the company can also generate cash from its balance sheet when collections accelerate. This pattern suggests that management has some discretion in timing payments and collections, which can smooth reported cash flow but may also obscure underlying trends.

The company has consistently returned cash to shareholders through dividends and buybacks, with buybacks showing a notable increase in 2026Q2 after a quieter period in 2025Q2. The acquisition activity has been modest, with the largest net outflow in 2025Q4 (-$1.6B) likely related to the Ovivo Electronics deal, which may explain the margin drag mentioned in the earnings commentary. The balance sheet appears to have limited leverage capacity, as suggested by the low debt/equity ratio, which could constrain future M&A unless the company issues equity or generates excess cash.

The cumulative OCF/NI ratio of approximately 1.33 over the trailing ten quarters suggests that the company's earnings are of high quality, with non-cash charges and working capital management contributing to cash generation. This divergence is a positive signal for investors, as it implies that the company is not relying on aggressive accruals to boost reported profits. However, the recent working capital outflows in 2026Q1 and Q2 may indicate that this trend is reversing, so investors should monitor whether the cumulative gap narrows in future quarters.